Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors on Outcomes After Catheter Ablation for Atrial Fibrillation
Hideyuki Kishima, Takanao Mine, Eiji Fukuhara, et al.
JACC. Clinical electrophysiology (2022) Vol. 8, Iss. 11, pp. 1393-1404
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Association between sodium–glucose cotransporter-2 inhibitors and arrhythmic outcomes in patients with diabetes and pre-existing atrial fibrillation
Akash Fichadiya, Amity E. Quinn, Flora Au, et al.
EP Europace (2024) Vol. 26, Iss. 3
Open Access | Times Cited: 14
Chinese guidelines for the diagnosis and management of atrial fibrillation
Changsheng Ma, Shulin Wu, Shaowen Liu, et al.
Pacing and Clinical Electrophysiology (2024) Vol. 47, Iss. 6, pp. 714-770
Closed Access | Times Cited: 9
The Role of Sodium Glucose Co-Transporter 2 Inhibitors in Atrial Fibrillation: A Comprehensive Review
Panagiotis Stachteas, Athina Nasoufidou, Efstratios Karagiannidis, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 18, pp. 5408-5408
Open Access | Times Cited: 8
Impact of sodium-glucose cotransporter 2 inhibitors on catheter ablation for atrial fibrillation in heart failure patients without type-2 diabetes
Masafumi Harada, Yuji Motoike, Y. Nomura, et al.
International Journal of Cardiology (2025) Vol. 422, pp. 132954-132954
Open Access | Times Cited: 1
Diabetes mellitus and atrial fibrillation-from pathophysiology to treatment
Marianna Leopoulou, Panagiotis Theofilis, Athanasios Kordalis, et al.
World Journal of Diabetes (2023) Vol. 14, Iss. 5, pp. 512-527
Open Access | Times Cited: 17
Impact of Sodium‐Glucose Cotransporter 2 Inhibitor on Recurrence After Catheter Ablation for Atrial Fibrillation in Patients With Diabetes: A Propensity‐Score Matching Study and Meta‐Analysis
Zixu Zhao, Chao Jiang, Liu He, et al.
Journal of the American Heart Association (2023) Vol. 12, Iss. 24
Open Access | Times Cited: 17
Efficacy of sodium-glucose cotransporter 2 inhibitors in preventing AF recurrence after catheter ablation
Panagiotis Stachteas, Paschalis Karakasis, Efstratios Karagiannidis, et al.
Hellenic Journal of Cardiology (2024) Vol. 79, pp. 86-87
Open Access | Times Cited: 7
SGLT2 inhibitors and the cardiac rhythm: unraveling the connections
Aritra Paul, Chadi Tabaja, Oussama M. Wazni
International Journal of Arrhythmia (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 5
The potential anti-arrhythmic effect of SGLT2 inhibitors
Hong-Yi Duan, Héctor Barajas-Martínez, Charles Antzelevitch, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Impact of Sodium‐Glucose Co‐Transporter 2 Inhibitors on Atrial Fibrillation Recurrence Post‐Catheter Ablation Among Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis
Naser Abdelhadi, Khaled Mohamed Ragab, Mohammed Elkholy, et al.
Journal of Cardiovascular Electrophysiology (2025)
Open Access
Effect of Sodium-Glucose Cotransporter Type 2 Inhibitors on The Development and Course of Atrial Fibrillation
D. A. Ishmaev, Magdalena Vasileva, D. V. Duplyakov
The Russian Archives of Internal Medicine (2025) Vol. 15, Iss. 1, pp. 17-23
Open Access
The Role of Early Risk Factor Modification and Ablation in Atrial Fibrillation Substrate Remodeling Prevention
Ioanna Koniari, Maria Bozika, Kassiani-Maria Nastouli, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 405-405
Open Access
The Impact of SGLT2 Inhibitors on Atrial Fibrillation Recurrence and Long‐Term Clinical Outcomes in HFrEF Patients Undergoing Cryoballoon Ablation: A New Frontier Beyond Diabetes and Heart Failure
Elif Hande Özcan Çetin, Mehmet Serkan Çetin, Hasan Can Könte, et al.
Journal of Cardiovascular Electrophysiology (2025)
Closed Access
Trends and disparities in diabetes and atrial fibrillation related mortality in the United States: 1999–2020
Muhammad Umer Sohail, Tayyab Khan, Mohammed Ahmed Sajid, et al.
Diabetes Research and Clinical Practice (2025), pp. 112112-112112
Open Access
Efficacy of sodium-glucose cotransporter 2 inhibitors on preventing atrial arrhythmia recurrences after atrial fibrillation ablation in patients with heart failure
Takashi Okajima, Shinji Ishikawa, Yusuke Uemura, et al.
Journal of Cardiology (2025)
Closed Access
Impact of SGLT2 Inhibitors on Atrial Fibrillation Recurrence after Catheter Ablation in Type 2 Diabetes Mellitus: A Meta-Analysis of Reconstructed Kaplan–Meier Curves with Trial Sequential Analysis
Youssef Soliman, Mohamed Abuelazm, Basma Ehab Amer, et al.
American Journal of Cardiovascular Drugs (2024) Vol. 24, Iss. 5, pp. 629-640
Open Access | Times Cited: 4
Repeat catheter ablation for atrial fibrillation
Mark Brahier, Daniel J. Friedman, Tristram D. Bahnson, et al.
Heart Rhythm (2023) Vol. 21, Iss. 4, pp. 471-483
Closed Access | Times Cited: 10
Atrial fibrillation: mechanism and clinical management
Zhicheng Hu, Ligang Ding, Yan Yao
Chinese Medical Journal (2023) Vol. 136, Iss. 22, pp. 2668-2676
Open Access | Times Cited: 9
Identification of key genes increasing susceptibility to atrial fibrillation in nonalcoholic fatty liver disease and the potential mechanisms: mitochondrial dysfunction and systemic inflammation
Baiyin Zhong, Zhonghui Xie, Jianhong Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Effect of early catheter ablation of atrial fibrillation in patients with heart failure
Patrik Tóth, B Arnoth, Ferenc Komlósi, et al.
Journal of Cardiovascular Electrophysiology (2024) Vol. 35, Iss. 7, pp. 1471-1479
Open Access | Times Cited: 3
Atrial fibrillation in cancer, anticancer therapies, and underlying mechanisms
Adnan Shaaban, Shane S. Scott, Ashley Greenlee, et al.
Journal of Molecular and Cellular Cardiology (2024) Vol. 194, pp. 118-132
Open Access | Times Cited: 3
Oxidative stress and atrial fibrillation
Anna Pfenniger, Shin Yoo, Rishi Arora
Journal of Molecular and Cellular Cardiology (2024) Vol. 196, pp. 141-151
Closed Access | Times Cited: 3
Prognostic value of glycaemic variability for mortality in critically ill atrial fibrillation patients and mortality prediction model using machine learning
Yang Chen, Zheng-kun Yang, Yang Liu, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Tofogliflozin long-term effects on atherosclerosis progression and major clinical parameters in patients with type 2 diabetes mellitus lacking a history of cardiovascular disease: a 2-year extension study of the UTOPIA trial
Naoto Katakami, Tomoya Mita, Hidenori Yoshii, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Adverse Events Requiring Hospitalization Following Catheter Ablation for Atrial Fibrillation in Heart Failure with versus without Systolic Dysfunction
Naoya Kataoka, Teruhiko Imamura, Takahisa Koi, et al.
Journal of Cardiovascular Development and Disease (2024) Vol. 11, Iss. 2, pp. 35-35
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top